NA20945
DNA from Fibroblast
Description:
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia
PHOSPHOMANNOMUTASE 2; PMM2
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Quantity |
10 µg |
Quantitation Method |
Please see our FAQ |
Biopsy Source
|
Unspecified
|
Cell Type
|
Fibroblast
|
Tissue Type
|
Skin
|
Transformant
|
Untransformed
|
Sample Source
|
DNA from Fibroblast
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin confirmed by LINE assay |
|
Gene |
PMM2 |
Chromosomal Location |
16p13.3-p13.2 |
Allelic Variant 1 |
601785.0016; CONGENITAL DISORDER OF GYLCOSYLATION, TYPE Ia |
Identified Mutation |
LEU32ARG; In a French patient with CDG Ia (212065), Vuillaumier-Barrot et al. (J Med Genet 37:579-580, 2000) identified a TA-to-GC substitution at nucleotide 95 in exon 2 of the PMM2 gene, resulting in a leu32-to-arg mutation.
|
|
Gene |
PMM2 |
Chromosomal Location |
16p13.3-p13.2 |
Allelic Variant 2 |
F157S; CONGENITAL DISORDER OF GYLCOSYLATION, TYPE Ia |
Identified Mutation |
PHE157SER |
Remarks |
Clinically affected; abnormal isoelectric focusing pattern of serum transferrin; mild phenotype; donor subject is a compound heterozygote: one allele has two nucleotides mutated in exon 2 of the PMM2 gene [95TA>GC] resulting in a substitution of arginine for leucine at codon 32 [Leu32Arg (L32R)] and a second allele has a T>C transition at nucleotide 470 in exon 6 of the PMM2 gene [470T>C] resulting in a substitution of serine for phenylalanine at codon 157 [Phe157Ser (F157S)].
|
Matthijs G, Schollen E, Bjursell C, Erlandson A, Freeze H, Imtiaz F, Kjaergaard S, Martinsson T, Schwartz M, Seta N, Vuillaumier-Barrot S, Westphal V, Winchester B, Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia) Human mutation16:386-94 2000 |
PubMed ID: 11058895 |
|
|